603 related articles for article (PubMed ID: 34581622)
1. A prenylated dsRNA sensor protects against severe COVID-19.
Wickenhagen A; Sugrue E; Lytras S; Kuchi S; Noerenberg M; Turnbull ML; Loney C; Herder V; Allan J; Jarmson I; Cameron-Ruiz N; Varjak M; Pinto RM; Lee JY; Iselin L; Palmalux N; Stewart DG; Swingler S; Greenwood EJD; Crozier TWM; Gu Q; Davies EL; Clohisey S; Wang B; Trindade Maranhão Costa F; Freire Santana M; de Lima Ferreira LC; Murphy L; Fawkes A; Meynert A; Grimes G; ; Da Silva Filho JL; Marti M; Hughes J; Stanton RJ; Wang ECY; Ho A; Davis I; Jarrett RF; Castello A; Robertson DL; Semple MG; Openshaw PJM; Palmarini M; Lehner PJ; Baillie JK; Rihn SJ; Wilson SJ
Science; 2021 Oct; 374(6567):eabj3624. PubMed ID: 34581622
[TBL] [Abstract][Full Text] [Related]
2. OAS1 and OAS3 negatively regulate the expression of chemokines and interferon-responsive genes in human macrophages.
Lee WB; Choi WY; Lee DH; Shim H; Kim-Ha J; Kim YJ
BMB Rep; 2019 Feb; 52(2):133-138. PubMed ID: 30078389
[TBL] [Abstract][Full Text] [Related]
3. Structure of the 5' untranslated region in SARS-CoV-2 genome and its specific recognition by innate immune system
Bignon E; Miclot T; Terenzi A; Barone G; Monari A
Chem Commun (Camb); 2022 Feb; 58(13):2176-2179. PubMed ID: 35060977
[TBL] [Abstract][Full Text] [Related]
4. Endomembrane targeting of human OAS1 p46 augments antiviral activity.
Soveg FW; Schwerk J; Gokhale NS; Cerosaletti K; Smith JR; Pairo-Castineira E; Kell AM; Forero A; Zaver SA; Esser-Nobis K; Roby JA; Hsiang TY; Ozarkar S; Clingan JM; McAnarney ET; Stone AE; Malhotra U; Speake C; Perez J; Balu C; Allenspach EJ; Hyde JL; Menachery VD; Sarkar SN; Woodward JJ; Stetson DB; Baillie JK; Buckner JH; Gale M; Savan R
Elife; 2021 Aug; 10():. PubMed ID: 34342578
[TBL] [Abstract][Full Text] [Related]
5. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Loss-of-Function Mutations Reveal Costs to OAS1 Antiviral Activity in Primates.
Carey CM; Govande AA; Cooper JM; Hartley MK; Kranzusch PJ; Elde NC
Cell Host Microbe; 2019 Feb; 25(2):336-343.e4. PubMed ID: 30713099
[TBL] [Abstract][Full Text] [Related]
7. A novel RNA molecular signature for activation of 2'-5' oligoadenylate synthetase-1.
Vachon VK; Calderon BM; Conn GL
Nucleic Acids Res; 2015 Jan; 43(1):544-52. PubMed ID: 25477390
[TBL] [Abstract][Full Text] [Related]
8. A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.
Calderon BM; Conn GL
J Biol Chem; 2018 Oct; 293(41):16115-16124. PubMed ID: 30126839
[TBL] [Abstract][Full Text] [Related]
9. Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication.
Lytras S; Wickenhagen A; Sugrue E; Stewart DG; Swingler S; Sims A; Jackson Ireland H; Davies EL; Ludlam EM; Li Z; Hughes J; Wilson SJ
PLoS Biol; 2023 Nov; 21(11):e3002398. PubMed ID: 38015855
[TBL] [Abstract][Full Text] [Related]
10. Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.
Danziger O; Patel RS; DeGrace EJ; Rosen MR; Rosenberg BR
PLoS Pathog; 2022 Apr; 18(4):e1010464. PubMed ID: 35421191
[TBL] [Abstract][Full Text] [Related]
11. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses.
Li Y; Banerjee S; Wang Y; Goldstein SA; Dong B; Gaughan C; Silverman RH; Weiss SR
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2241-6. PubMed ID: 26858407
[TBL] [Abstract][Full Text] [Related]
12. Length dependent activation of OAS proteins by dsRNA.
Wang Y; Holleufer A; Gad HH; Hartmann R
Cytokine; 2020 Feb; 126():154867. PubMed ID: 31629990
[TBL] [Abstract][Full Text] [Related]
13. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.
Kristiansen H; Gad HH; Eskildsen-Larsen S; Despres P; Hartmann R
J Interferon Cytokine Res; 2011 Jan; 31(1):41-7. PubMed ID: 21142819
[TBL] [Abstract][Full Text] [Related]
14. Functional evolution of the OAS1 viral sensor: Insights from old world primates.
Fish I; Boissinot S
Infect Genet Evol; 2016 Oct; 44():341-350. PubMed ID: 27393659
[TBL] [Abstract][Full Text] [Related]
15. A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.
Anisul M; Shilts J; Schwartzentruber J; Hayhurst J; Buniello A; Shaikho Elhaj Mohammed E; Zheng J; Holmes M; Ochoa D; Carmona M; Maranville J; Gaunt TR; Emilsson V; Gudnason V; McDonagh EM; Wright GJ; Ghoussaini M; Dunham I
Elife; 2021 Aug; 10():. PubMed ID: 34402426
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antiviral action of interferon.
Baglioni C; Nilsen TW
Interferon; 1983; 5():23-42. PubMed ID: 6202642
[No Abstract] [Full Text] [Related]
17. Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting interferon production.
Harioudh MK; Perez J; Chong Z; Nair S; So L; McCormick KD; Ghosh A; Shao L; Srivastava R; Soveg F; Ebert TS; Atianand MK; Hornung V; Savan R; Diamond MS; Sarkar SN
Immunity; 2024 Mar; 57(3):446-461.e7. PubMed ID: 38423012
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
19. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
Torrence PF
Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
